Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China
NCT02955316 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2018-11-07
Summary
The primary objective of this study is to estimate the overall prevalence of IBS medically diagnosed and diagnosed using Rome III or IV criteria in GI adult outpatients in China.
Conditions
- Irritable Bowel Syndrome (IBS)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Xiaohua Hou, PhD · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-10
- Primary Completion
- 2017-09-30
- Completion
- 2017-09-30
Countries
- China
Study Locations
More Related Trials
-
Small and Large Bowel Transit Tests Using MRI (Study 1)
NCT01534507 ·Status: COMPLETED
-
Traditional Chinese Medicine for Treatment of Irritable Bowel Syndrome
NCT03135821 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome
NCT03457324 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Predictive Value of Alarm Symptoms in Patients With Irritable Bowel Syndrome Based on Rome IV
NCT03620994 ·Status: UNKNOWN
-
Investigation of Acupoint in Irritable Bowel Syndrome Based on Biological Characteristics
NCT06365801 ·Status: NOT_YET_RECRUITING
-
Changes of Microbiota in Irritable Bowel Syndrome Patients
NCT01679730 ·Status: UNKNOWN
-
Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase
NCT02566629 ·Status: UNKNOWN
-
Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrome in the Russian Federation
NCT03549143 ·Status: COMPLETED
-
Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)
NCT03471728 ·Status: COMPLETED
-
Study on the Molecular Mechanism of Diarrhea-predominant Irritable Bowel Syndrome With Anxiety and Depression Based on Multi-omics Correlation Analysis
NCT05311293 ·Status: UNKNOWN
-
FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment
NCT03125564 ·Status: COMPLETED ·Phase: NA
-
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569 ·Status: NOT_YET_RECRUITING
-
Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS)
NCT03300804 ·Status: COMPLETED ·Phase: PHASE2
-
Primary Headaches and Irritable Bowel Syndrome.
NCT05057533 ·Status: UNKNOWN
-
Prevalence of Irritable Bowel Syndrome in Medical Students Africa
NCT06097598 ·Status: NOT_YET_RECRUITING
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1
-
"Functional Bowel Disorder. Investigation in General Practice"
NCT01153295 ·Status: COMPLETED ·Phase: NA
-
Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome
NCT01028898 ·Status: UNKNOWN
-
Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea
NCT02822118 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Xiang-Sha-Liu-Jun-Zi-Tang in Patients With Irritable Bowel Syndrome
NCT02179580 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Immunological Change and the Single Nucleotide Polymorphism (SNP) in Children With Irritable Bowel Syndrome (IBS)
NCT01131442 ·Status: UNKNOWN
-
Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)
NCT01072916 ·Status: COMPLETED
-
Efficacy of Low-FODMAPs Dietary Therapy for Irritable Bowel Syndrome in China
NCT03304041 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome
NCT00676975 ·Status: COMPLETED ·Phase: PHASE2